Skip to main content
Erschienen in: Malaria Journal 1/2009

Open Access 01.12.2009 | Commentary

Knowlesi malaria in Vietnam

verfasst von: Janet Cox-Singh

Erschienen in: Malaria Journal | Ausgabe 1/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

The simian malaria parasite Plasmodium knowlesi is transmitted in the forests of Southeast Asia. Symptomatic zoonotic knowlesi malaria in humans is widespread in the region and is associated with a history of spending time in the jungle. However, there are many settings where knowlesi transmission to humans would be expected but is not found. A recent report on the Ra-glai population of southern central Vietnam is taken as an example to help explain why this may be so.
Hinweise

Competing interests

The authors declares no competing interests.

Background

A recent study on Plasmodium knowlesi malaria in Vietnam failed to discover symptomatic P. knowlesi in the human population [1]. In their study, the authors used P. knowlesi PCR primers to re-examine blood samples collected during two large cross-sectional malaria surveys in the Ninh Thuan province during 2004 and 2005. The population screened was mainly of Ra-glai ethnicity, living in hilly, densely forested areas with frequent overnight stays in the jungle. There are many parallels with the population in Sarawak Malaysian Borneo, where a large number of human cases of zoonotic knowlesi malaria occur annually [2, 3]. The authors report that vectors of P. knowlesi are in the area, but it is not known if there are macaques or indeed if they carry P. knowlesi parasites [4]. Nonetheless, all of the indicators suggest that human cases of P. knowlesi could occur in this population, which is, therefore, worthy of screening.

Discussion

The authors reported that during their surveys 13.6% of 4,000 individuals screened were PCR positive for the human-adapted malaria parasites, PCR for P. knowlesi was not included. Of the positives, 210 were Plasmodium malariae. Ninety-five of the 210 were selected for re-screening with P. knowlesi PCR primers. Three samples, two from children, two and three years of age respectively, and one from a young adult were confirmed P. knowlesi PCR-positive. One of the children remained positive with time. The authors conclude that the prevalence of P. knowlesi is low and asymptomatic in this population. This finding is not surprising given that the authors re-screened samples PCR-positive for P. malariae. Plasmodium malariae and P. knowlesi are phylogenetically distinct, the one notable similarity is at the morphological level. Indistinguishable morphology between these parasites gave rise to misdiagnosis and masking of symptomatic human cases of P. knowlesi malaria in Sarawak, often putting patients lives at risk [3]. Therefore, to screen properly this important population in Vietnam for P. knowlesi infection, PCR negative samples found during the primary screen, those that were not amplified by falciparum, vivax, malariae or ovale specific PCR primers, would have been more likely to yield positive results for P. knowlesi. Of the three P. knowlesi positives reported, one was negative by microscopy and the others were either P. vivax or P. vivax with P. falciparum by microscopy. For this study, the authors used P. knowlesi primers Pmk8 and Pmk9 published by the Sarawak research group [3]. These primers have recently been reported to cross-hybridize with a small number of Plasmodium vivax isolates in a stochastic (random) manner [5]. Two of the three positive cases had microscopy confirmed P. vivax. It is possible that the persistent infection reported was due to cross-hybridization with P. vivax, an explanation that would better fit the biology of the two parasites. Taken together with sampling and other problems involving non-specific human DNA amplification reported by Van den Eede et al, this account of P. knowlesi in Vietnam may not accurately represent the situation there.

Conclusion

Persistent P. knowlesi infections, particularly in very young children would indeed add interest to what is currently known of P. knowlesi epidemiology. Cryptic knowlesi infections were reported recently in Thailand [6], but mostly as mixed infections with P. falciparum and P. vivax and in areas where these human malaria parasites predominate. The cases of P. falciparum and P. vivax in Sarawak, Malaysian Borneo, are in decline, particularly in areas where symptomatic P. knowlesi is reported. Plasmodium knowlesi remains zoonotic and by definition less well-adapted to the human host. In areas where Plasmodium falciparum and P. vivax are prevalent, they would perhaps be expected to out-compete P. knowlesi in the human host. It will be interesting to follow the incidence of symptomatic knowlesi malaria in neighbouring countries, particularly when the human-adapted parasites are in decline and where humans continue to utilize forested areas with known knowlesi transmission.

Acknowledgements

I wish to thank Sanjeev Krishna and Balbir Singh for their helpful comments.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declares no competing interests.
Literatur
1.
Zurück zum Zitat Eede Van den P, Nguyen Van H, Van Overmeir C, Vythilingam I, Ngo Duc T, Xuan Hung L, Nguyen Manh H, Anne J, D'Alessandro U, Erhart A: Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J. 2009, 8: 249-10.1186/1475-2875-8-249.PubMedCentralCrossRefPubMed Eede Van den P, Nguyen Van H, Van Overmeir C, Vythilingam I, Ngo Duc T, Xuan Hung L, Nguyen Manh H, Anne J, D'Alessandro U, Erhart A: Human Plasmodium knowlesi infections in young children in central Vietnam. Malar J. 2009, 8: 249-10.1186/1475-2875-8-249.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Cox-Singh J, Singh B: Knowlesi malaria: newly emergent and of public health importance?. Trends Parasitol. 2008, 24: 406-410. 10.1016/j.pt.2008.06.001.PubMedCentralCrossRefPubMed Cox-Singh J, Singh B: Knowlesi malaria: newly emergent and of public health importance?. Trends Parasitol. 2008, 24: 406-410. 10.1016/j.pt.2008.06.001.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ: A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004, 363: 1017-1024. 10.1016/S0140-6736(04)15836-4.CrossRefPubMed Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ: A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004, 363: 1017-1024. 10.1016/S0140-6736(04)15836-4.CrossRefPubMed
4.
Zurück zum Zitat Seethamchai S, Putaporntip C, Malaivijitnod S, Cui L, Jongwutiwes S: Malaria and hepatocystis species in wild macaques, southern Thailand. Am J Trop Med Hyg. 2008, 78: 646-653.PubMed Seethamchai S, Putaporntip C, Malaivijitnod S, Cui L, Jongwutiwes S: Malaria and hepatocystis species in wild macaques, southern Thailand. Am J Trop Med Hyg. 2008, 78: 646-653.PubMed
5.
Zurück zum Zitat Imwong M, Tanomsing N, Pukrittayakamee S, Day NP, White NJ, Snounou G: Spurious amplification of P. vivax small subunit RNA gene using the primers currently used to detect P. knowlesi. J Clin Microbiol. 2009, Published ahead of print 7th October 0:JCM.00811-09 Imwong M, Tanomsing N, Pukrittayakamee S, Day NP, White NJ, Snounou G: Spurious amplification of P. vivax small subunit RNA gene using the primers currently used to detect P. knowlesi. J Clin Microbiol. 2009, Published ahead of print 7th October 0:JCM.00811-09
6.
Zurück zum Zitat Putaporntip C, Hongsrimuang T, Seethamchai S, Kobasa T, Limkittikul K, Cui L, Jongwutiwes S: Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis. 2009, 199: 1143-1150. 10.1086/597414.CrossRefPubMed Putaporntip C, Hongsrimuang T, Seethamchai S, Kobasa T, Limkittikul K, Cui L, Jongwutiwes S: Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis. 2009, 199: 1143-1150. 10.1086/597414.CrossRefPubMed
Metadaten
Titel
Knowlesi malaria in Vietnam
verfasst von
Janet Cox-Singh
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
Malaria Journal / Ausgabe 1/2009
Elektronische ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-8-269

Weitere Artikel der Ausgabe 1/2009

Malaria Journal 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.